Track CTXR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CTXR - Citius Pharmaceuticals Inc (CTXR) has a earnings per share of -$0.95, up 25.2% over the past year.
Latest EPS (Actual)
-$0.95
Beat Rate
12.5%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.32 | -$0.95 | Miss | -196.87% |
| Feb 2026 | -$0.30 | -$0.38 | Miss | -26.67% |
| Dec 2025 | -$0.24 | -$0.11 | Beat | +54.17% |
| Aug 2025 | -$0.21 | -$0.80 | Miss | -280.95% |
| May 2025 | $0.11 | -$1.27 | Miss | -1254.55% |
| Feb 2025 | -$1.25 | -$1.30 | Meet | -4.00% |
| Dec 2024 | -$1.50 | -$5.80 | Miss | -286.67% |
| Aug 2024 | -$1.12 | -$1.50 | Miss | -33.93% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.